Technologie medyczne
Firmy argentyńskie działające w jednym sektorze: technologie medyczne
Te Firmy argentyńskie działają w tym samym sektorze, technologie medyczne. Znajdziesz tu ich ceny, zmiany i inne statystyki, które pomogą Ci poznać jak najwięcej szczegółów. Lista zawiera akcje dla dowolnej strategii: giganty o dużej kapitalizacji, takie jak ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1, spółki o największych zyskach, takie jak AMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) i nie tylko. Filtruj listę i w wygodny sposób sprawdzaj wyniki firm.
Symbol | Kapitalizacja rynkowa | Cena | Zmiana % | Wolumen | Realny Wolumen | Cena/Zysk | Zysk na akcję rzeczywisty TTM | Wzrost rzeczywistego zysku na akcję Ostatnie 12 miesięcy r/r | Rentowność dywidend % TTM | Ocena Analityków |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 886,23 T ARS | 19 550,000 ARS | +1,30% | 13,13 K | 2,25 | 102,98 | 189,84 ARS | +513,89% | 0,28% | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 886,23 T ARS | 16,200 USD | +1,89% | 557 | 1,25 | 87,98 | 189,84 ARS | +381,39% | 0,28% | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 418,05 T ARS | 13 400,000 ARS | +1,13% | 207,73 K | 4,85 | 38,02 | 352,44 ARS | +193,52% | 1,48% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 418,05 T ARS | 1 300,000 ARS | 0,00% | 38 | 1,21 | — | — | — | — | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 418,05 T ARS | 11,050 USD | +0,45% | 1,23 K | 1,43 | 32,32 | 352,44 ARS | +130,17% | 1,48% | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 382,05 T ARS | 24 700,000 ARS | −0,70% | 1,14 K | 1,26 | 11,62 | 2 124,76 ARS | +164,67% | 1,57% | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 382,05 T ARS | 20,450 USD | +0,74% | 156 | 3,43 | 9,92 | 2 124,76 ARS | +107,54% | 1,57% | — |
 ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1DR | 248,19 T ARS | 41 050,000 ARS | +0,06% | 284 | 0,65 | 22,18 | 1 850,70 ARS | +652,64% | 0,85% | — |
| ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 248,19 T ARS | 33,250 USD | +0,30% | 37 | 2,61 | 18,52 | 1 850,70 ARS | +490,19% | 0,85% | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 244,84 T ARS | 22 050,000 ARS | −0,56% | 4,08 K | 0,47 | 18,06 | 1 220,67 ARS | +16 053,66% | 1,69% | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 244,84 T ARS | 18,600 USD | +1,36% | 26 | 0,16 | 15,71 | 1 220,67 ARS | +12 566,98% | 1,69% | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 244,36 T ARS | 45 650,000 ARS | +0,55% | 781 | 1,40 | 55,95 | 815,85 ARS | +292,28% | 1,26% | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 244,36 T ARS | 37,700 USD | +1,48% | 7 | 0,02 | 47,64 | 815,85 ARS | +207,61% | 1,26% | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 230,36 T ARS | 33 225,000 ARS | +0,30% | 2,18 K | 6,33 | 5,66 | 5 874,32 ARS | −4,22% | 3,35% | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 230,36 T ARS | 27,200 USD | +4,82% | 1 | 0,32 | 4,77 | 5 874,32 ARS | −24,89% | 3,35% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 223,53 T ARS | 7 700,000 ARS | −3,75% | 210 | 2,53 | 117,46 | 65,55 ARS | +275,33% | 0,00% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 214,25 T ARS | 29 800,000 ARS | +0,34% | 3,13 K | 3,03 | 43,04 | 692,31 ARS | +225,19% | 0,14% | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 176,44 T ARS | 12 750,000 ARS | +1,39% | 2,07 K | 1,89 | 56,57 | 225,39 ARS | −12,23% | 1,95% | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 176,44 T ARS | 10,700 USD | +4,90% | 38 | 1,11 | 48,94 | 225,39 ARS | −31,17% | 1,95% | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 160,15 T ARS | 8 090,000 ARS | +0,25% | 27,68 K | 1,11 | 25,48 | 317,52 ARS | — | 3,35% | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 160,15 T ARS | 6,710 USD | +0,15% | 2,02 K | 1,39 | 21,79 | 317,52 ARS | — | 3,35% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 160,03 T ARS | 4 705,000 ARS | −1,36% | 1,2 K | 0,82 | 52,51 | 89,60 ARS | +164,69% | 0,21% | — |
| DHRDDANAHER CORP CEDEAR EACH 54 REPR 1 ORD UNSPON USD DR | 160,03 T ARS | 4,060 USD | 0,00% | 3 | — | 46,71 | 89,60 ARS | +107,56% | 0,21% | — |
 GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001DR | 146,74 T ARS | 34 000,000 ARS | +1,04% | 1,7 K | 4,35 | 189,41 | 179,50 ARS | −48,35% | 1,35% | — |
| GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 146,74 T ARS | 27,500 USD | +0,73% | 5 | 0,26 | 157,94 | 179,50 ARS | −59,50% | 1,35% | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 124,56 T ARS | 23 650,000 ARS | +0,96% | 3,18 K | 5,36 | — | −1 193,64 ARS | −422,98% | 2,45% | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USD DR | 124,56 T ARS | 19,300 USD | +0,52% | 2 | 0,19 | — | −1 193,64 ARS | −353,26% | 2,45% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 122,61 T ARS | 27 500,000 ARS | +0,18% | 156 | 0,28 | 35,19 | 781,38 ARS | +170,70% | 1,79% | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 79,37 T ARS | 11 600,000 ARS | +3,34% | 3,09 K | 5,57 | 33,26 | 348,78 ARS | +79,50% | 2,81% | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 79,37 T ARS | 9,570 USD | +4,70% | 26 | 0,62 | 28,29 | 348,78 ARS | +40,76% | 2,81% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 25,83 T ARS | 6 450,000 ARS | +2,06% | 5,06 K | 1,80 | — | −805,76 ARS | −85,28% | 0,00% | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 21,93 T ARS | 13 325,000 ARS | +1,14% | 6,28 K | 3,25 | 17,12 | 778,26 ARS | +389,90% | 0,00% | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 21,93 T ARS | 11,500 USD | +4,07% | 20 | 0,95 | 15,23 | 778,26 ARS | +284,16% | 0,00% | — |
 MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORDDR | 13,87 T ARS | 2 150,000 ARS | −0,92% | 65,38 K | 0,43 | — | −419,57 ARS | −136,20% | 0,00% | — |
| MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD) DR | 13,87 T ARS | 1,780 USD | −2,73% | 24 | 0,05 | — | −419,57 ARS | −85,22% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 133,64 B ARS | 1 540,000 ARS | −6,95% | 17,86 K | 1,48 | 15,99 | 96,29 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 5,11 B ARS | 112,000 ARS | −6,67% | 2,1 K | 2,05 | 26,24 | 4,27 ARS | +64,50% | 0,00% | — |